Literature DB >> 31486477

MicroRNA-579-3p promotes the progression of osteoporosis by inhibiting osteogenic differentiation of mesenchymal stem cells through regulating Sirt1.

B Luo1, J-F Yang, Y-H Wang, G-B Qu, P-D Hao, Z-J Zeng, J Yuan, R Yang, Y Yuan.   

Abstract

OBJECTIVE: To explore whether microRNA-579-3P was involved in the development of osteoporosis, and to investigate the possible molecular mechanisms. PATIENTS AND METHODS: The messenger RNA (mRNA) expression levels of microRNA-579-3P, alkaline phosphatase (ALP), runt-related transcription factor 2 (RUNX2) and bone sialoprotein (BSP) in serum samples of osteoporosis patients and normal controls were detected by quantitative Real-time polymerase chain reaction (qRT-PCR), respectively. Meanwhile, the expressions of the above genes during osteogenic differentiation of human bone marrow mesenchymal stem cells (hMSCs) were examined as well. To investigate the effect of microRNA-579-3P on osteogenesis, microRNA-579-3P was overexpressed and knocked down in hMSCs. Subsequently, the mRNA and protein expression levels of osteogenesis-related genes, such as ALP, RUNX2 and BSP, were detected by qRT-PCR and Western blot, respectively. In addition, ALP activity and mineralization forming ability were evaluated by ALP staining and alizarin red staining. Bioinformatics predicted that Sirt1 was the target gene of microRNA-579-3P. Subsequent luciferase reporter gene assay was performed to verify the binding relationship of microRNA-579-3P to Sirt1. Meanwhile, qRT-PCR and Western blot were used to detect the changes in the mRNA and protein expression levels of Sirt1, respectively. After overexpression of microRNA-579-3P and Sirt1, qRT-PCR, Western blot, ALP staining and alizarin red staining assays were performed to detect the osteogenic differentiation of hMSCs.
RESULTS: The expression of microRNA-579-3P in serum of patients with osteoporosis was significantly higher than that of normal controls. Meanwhile, the expression of microRNA-579-3P decreased gradually during osteogenic differentiation of hMSCs. Overexpression of microRNA-579-3P significantly reduced the expressions of osteogenic related genes, including ALP, RUNX2 and BSP. Besides, ALP activity and mineralized nodule formation ability decreased obviously as well. Luciferase reporter gene assay showed that microRNA-579-3P could bind to Sirt1. After overexpression of microRNA-579-3P, the mRNA and protein expression levels of Sirt1 were significantly reduced, which were reversed after silence of microRNA-579-3P. Simultaneous overexpression of microRNA-579-3P and Sirt1 could reverse the inhibition of osteogenic differentiation of hMSCs caused by overexpression of microRNA-579-3P alone.
CONCLUSIONS: MicroRNA-579-3P could inhibit osteogenic differentiation of hMSCs by regulating Sirt1, thereby promoting the development of osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31486477     DOI: 10.26355/eurrev_201908_18717

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  8 in total

Review 1.  The Emerging Role of Non-Coding RNAs in Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells.

Authors:  Xiaoying Chen; Wei Xie; Ming Zhang; Yuhan Shi; Shaofen Xu; Haoyu Cheng; Lihong Wu; Janak L Pathak; Zhichao Zheng
Journal:  Front Cell Dev Biol       Date:  2022-05-16

Review 2.  The Role of Micro RNA and Long-Non-Coding RNA in Osteoporosis.

Authors:  Nai-Yu Ko; Li-Ru Chen; Kuo-Hu Chen
Journal:  Int J Mol Sci       Date:  2020-07-10       Impact factor: 5.923

Review 3.  The Emerging Role of MicroRNAs in Bone Diseases and Their Therapeutic Potential.

Authors:  Luis Alberto Bravo Vázquez; Mariana Yunuen Moreno Becerril; Erick Octavio Mora Hernández; Gabriela García de León Carmona; María Emilia Aguirre Padilla; Samik Chakraborty; Anindya Bandyopadhyay; Sujay Paul
Journal:  Molecules       Date:  2021-12-30       Impact factor: 4.411

Review 4.  The Landscape of lncRNAs in Multiple Myeloma: Implications in the "Hallmarks of Cancer", Clinical Perspectives and Therapeutic Opportunities.

Authors:  Ilaria Saltarella; Benedetta Apollonio; Aurelia Lamanuzzi; Vanessa Desantis; Maria Addolorata Mariggiò; Jean-François Desaphy; Angelo Vacca; Maria Antonia Frassanito
Journal:  Cancers (Basel)       Date:  2022-04-13       Impact factor: 6.575

Review 5.  Osteoporosis pathogenesis and treatment: existing and emerging avenues.

Authors:  Shu Lin; Yan-Chuan Shi; Bo Liang; George Burley
Journal:  Cell Mol Biol Lett       Date:  2022-09-04       Impact factor: 8.702

Review 6.  The Role of MicroRNAs in Bone Metabolism and Disease.

Authors:  Yongguang Gao; Suryaji Patil; Airong Qian
Journal:  Int J Mol Sci       Date:  2020-08-24       Impact factor: 5.923

Review 7.  Circulating MicroRNAs as Novel Biomarkers for Osteoporosis and Fragility Fracture Risk: Is There a Use in Assessment Risk?

Authors:  Simone Ciuffi; Simone Donati; Francesca Marini; Gaia Palmini; Ettore Luzi; Maria Luisa Brandi
Journal:  Int J Mol Sci       Date:  2020-09-21       Impact factor: 5.923

Review 8.  Application of microRNA in Human Osteoporosis and Fragility Fracture: A Systemic Review of Literatures.

Authors:  Yen-Zung Wu; Hsuan-Ti Huang; Tsung-Lin Cheng; Yen-Mou Lu; Sung-Yen Lin; Cheng-Jung Ho; Tien-Ching Lee; Chia-Hao Hsu; Peng-Ju Huang; Han Hsiang Huang; Jhong-You Li; Yu-De Su; Shih-Chieh Chen; Lin Kang; Chung-Hwan Chen
Journal:  Int J Mol Sci       Date:  2021-05-15       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.